Senior External Innovation & Partnerships Lead (Remote)

Travere Therapeutics; Detroit (MI); On-site; USD 150,000 - 195,000; Full time

Job summary

Travere Therapeutics is seeking an Associate Director, Search and Evaluation to identify and evaluate external innovation for in-licensing, acquisitions or collaborations. You will collaborate with scientific experts to shape strategy in rare diseases.

The role requires leading scientific assessments, partnering with cross-functional teams, and building industry relationships while staying current on trends and opportunities. Travel up to 30% is expected.

Qualifications

• Bachelor's degree in Life Sciences or related field; advanced degree preferred.
• 8+ years of relevant scientific experience in biotech/pharma with business development focus.

Responsibilities

• Collaborate with scientific leaders to define external innovation strategy in nephrology and rare diseases.
• Identify leads and source new business development opportunities aligned with Travere's goals.
• Conduct thorough scientific evaluations of potential in-licensing, acquisitions, or collaborations.
• Be a key member of the cross-functional deal team through diligence, negotiation, and integration.
• Build relationships with researchers, industry experts, and potential partners.
• Stay informed on industry trends, technologies, and competitive activity.
• Use multiple information sources to identify promising assets and opportunities.

Education

Bachelor's degree in Life Sciences or related

Advanced degree such as PhD, PharmD, MD, MS, or MBA preferred

Job description

Travere Therapeutics is seeking an Associate Director, Search and Evaluation to identify and evaluate external innovation for in-licensing, acquisitions or collaborations. You will collaborate with scientific experts to shape strategy in rare diseases.

The role requires leading scientific assessments, partnering with cross-functional teams, and building industry relationships while staying current on trends and opportunities. Travel up to 30% is expected.